{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:48:43Z","timestamp":1758127723800},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pain after surgery remains a significant healthcare challenge. Here, abobotulinumtoxinA (aboBoNT-A, DYSPORT) was assessed in a post-surgical pain model in pigs. Full-skin-muscle incision and retraction surgery on the lower back was followed by intradermal injections of either aboBoNT-A (100, 200, or 400 U\/pig), vehicle (saline), or wound infiltration of extended-release bupivacaine. We assessed mechanical sensitivity, distress behaviors, latency to approach the investigator, and wound inflammation\/healing for 5\u20136\u00a0days post-surgery. We followed with immunohistochemical analyses of total and cleaved synaptosomal-associated protein 25 kD (SNAP25), glial fibrillary acidic protein (GFAP), ionized calcium-binding adaptor protein-1(Iba1), calcitonin gene-related peptide (CGRP) and substance P (SP) in the skin, dorsal root ganglia (DRG) and the spinal cord of 400 U aboBoNT-A- and saline-treated animals. At Day 1, partial reversal of mechanical allodynia in aboBoNT-A groups was followed by a full reversal from Day 3. Reduced distress and normalized approaching responses were observed with aboBoNT-A from 6\u00a0h post-surgery. Bupivacaine reversed mechanical allodynia for 24\u00a0h after surgery but did not affect distress or approaching responses. In aboBoNT-A-treated animals cleaved SNAP25 was absent in the skin and DRG, but present in the ipsilateral dorsal horn of the spinal cord. In aboBoNT-A- versus saline-treated animals there were significant reductions in GFAP and Iba1 in the spinal cord, but no changes in CGRP and SP. Analgesic efficacy of aboBoNT-A appears to be mediated by its activity on spinal neurons, microglia and astrocytes. Clinical investigation to support the use of aboBoNT-A as an analgesic drug for post-surgical pain, is warranted.<\/jats:p>","DOI":"10.1038\/s41598-022-25002-x","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T16:10:49Z","timestamp":1670947849000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Intraoperative abobotulinumtoxinA alleviates pain after surgery and improves general wellness in a translational animal model"],"prefix":"10.1038","volume":"12","author":[{"given":"Sylvie","family":"Cornet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Carr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Limana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Castel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigal","family":"Meilin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Horne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Pons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephane","family":"Lezmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail","family":"Kalinichev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"25002_CR1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1213\/01.ANE.0000068822.10113.9E","volume":"97","author":"JL Apfelbaum","year":"2003","unstructured":"Apfelbaum, J. L., Chen, C., Mehta, S. S. & Gan, T. J. Postoperative pain experience: Results from a national survey suggest postoperative pain continues to be undermanaged. Anesth. Analg. 97, 534\u2013540 (2003).","journal-title":"Anesth. Analg."},{"key":"25002_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ejpain.2011.06.004","volume":"16","author":"V Lorentzen","year":"2012","unstructured":"Lorentzen, V., Hermansen, I. L. & Botti, M. A prospective analysis of pain experience, beliefs and attitudes, and pain management of a cohort of Danish surgical patients. Eur. J. Pain 16, 278\u2013288 (2012).","journal-title":"Eur. J. Pain"},{"key":"25002_CR3","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/ALN.0000000000001012","volume":"124","author":"ED Kharasch","year":"2016","unstructured":"Kharasch, E. D. & Michael Brunt, L. Perioperative opioids and public health. Anesthesiology 124, 960\u2013965 (2016).","journal-title":"Anesthesiology"},{"key":"25002_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.toxicon.2013.05.003","volume":"75","author":"MR Popoff","year":"2013","unstructured":"Popoff, M. R. & Bouvet, P. Genetic characteristics of toxigenic Clostridia and toxin gene evolution. Toxicon 75, 63\u201389 (2013).","journal-title":"Toxicon"},{"key":"25002_CR5","doi-asserted-by":"crossref","unstructured":"Pirazzini, M., Rossetto, O., Eleopra, R. & Montecucco, C. Botulinum neurotoxins: Biology, pharmacology, and toxicology. Pharmacol. Rev. 69 (2017).","DOI":"10.1124\/pr.116.012658"},{"key":"25002_CR6","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.3390\/toxins2122890","volume":"2","author":"F Pavone","year":"2010","unstructured":"Pavone, F. & Luvisetto, S. Botulinum neurotoxin for pain management: Insights from animal models. Toxins (Basel) 2, 2890\u20132913 (2010).","journal-title":"Toxins (Basel)"},{"key":"25002_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pneurobio.2014.06.001","volume":"119\u2013120","author":"I Matak","year":"2014","unstructured":"Matak, I. & Lackovi\u0107, Z. Botulinum toxin A, brain and pain. Prog. Neurobiol. 119\u2013120, 39\u201359 (2014).","journal-title":"Prog. Neurobiol."},{"key":"25002_CR8","first-page":"496","volume":"18","author":"D Castel","year":"2014","unstructured":"Castel, D., Willentz, E., Doron, O., Brenner, O. & Meilin, S. Characterization of a porcine model of post-operative pain. Eur. J. Pain (United Kingdom) 18, 496\u2013505 (2014).","journal-title":"Eur. J. Pain (United Kingdom)"},{"key":"25002_CR9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/0300985811402846","volume":"49","author":"MM Swindle","year":"2012","unstructured":"Swindle, M. M., Makin, A., Herron, A. J., Clubb, F. J. & Frazier, K. S. Swine as models in biomedical research and toxicology testing. Vet. Pathol. 49, 344\u2013356 (2012).","journal-title":"Vet. Pathol."},{"key":"25002_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.molimm.2014.10.023","volume":"66","author":"A Summerfield","year":"2015","unstructured":"Summerfield, A., Meurens, F. & Ricklin, M. E. The immunology of the porcine skin and its value as a model for human skin. Mol. Immunol. 66, 14\u201321 (2015).","journal-title":"Mol. Immunol."},{"key":"25002_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pain.2010.11.005","volume":"152","author":"TJ Brennan","year":"2011","unstructured":"Brennan, T. J. Pathophysiology of postoperative pain. Pain 152, 33\u201340 (2011).","journal-title":"Pain"},{"key":"25002_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/j.pain.0000000000000375","volume":"157","author":"SA Cooper","year":"2016","unstructured":"Cooper, S. A. et al. Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations. Pain 157, 288\u2013301 (2016).","journal-title":"Pain"},{"key":"25002_CR13","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/j.pain.2011.02.008","volume":"152","author":"S Srikandarajah","year":"2011","unstructured":"Srikandarajah, S. & Gilron, I. Systematic review of movement-evoked pain versus pain at rest in postsurgical clinical trials and meta-analyses: A fundamental distinction requiring standardized measurement. Pain 152, 1734\u20131739 (2011).","journal-title":"Pain"},{"key":"25002_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0304-3959(95)01441-1","volume":"64","author":"TJ Brennan","year":"1996","unstructured":"Brennan, T. J., Vandermeulen, E. P. & Gebhart, G. F. Characterization of a rat model of incisional pain. Pain 64, 493\u2013502 (1996).","journal-title":"Pain"},{"key":"25002_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12893-016-0120-y","volume":"16","author":"MM Ghoneim","year":"2016","unstructured":"Ghoneim, M. M. & O\u2019Hara, M. W. Depression and postoperative complications: An overview Visceral and general surgery. BMC Surg. 16, 1\u201310 (2016).","journal-title":"BMC Surg."},{"key":"25002_CR16","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/EJA.0000000000000052","volume":"32","author":"F Kouya","year":"2015","unstructured":"Kouya, F., Iqbal, Z., Charen, D., Shah, M. & Banik, R. K. Evaluation of anxiety-like behaviour in a rat model of acute postoperative pain. Eur. J. Anaesthesiol. 32, 242\u2013247 (2015).","journal-title":"Eur. J. Anaesthesiol."},{"key":"25002_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-015-0140-z","volume":"8","author":"C Su","year":"2015","unstructured":"Su, C. et al. Persistent pain alters AMPA receptor subunit levels in the nucleus accumbens. Mol. Brain 8, 1\u201317 (2015).","journal-title":"Mol. Brain"},{"key":"25002_CR18","first-page":"885","volume":"7","author":"M Lambrechts","year":"2013","unstructured":"Lambrechts, M., O\u2019Brien, M. J., Savoie, F. H. & You, Z. Liposomal extended-release bupivacaine for postsurgical analgesia. Patient Prefer. Adherence 7, 885\u2013890 (2013).","journal-title":"Patient Prefer. Adherence"},{"key":"25002_CR19","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.2147\/JPR.S144949","volume":"10","author":"D Castel","year":"2017","unstructured":"Castel, D., Sabbag, I. & Meilin, S. The effect of local\/topical analgesics on incisional pain in a pig model. J. Pain Res. 10, 2169\u20132175 (2017).","journal-title":"J. Pain Res."},{"key":"25002_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.pneurobio.2018.06.012","volume":"169","author":"A Merighi","year":"2018","unstructured":"Merighi, A. The histology, physiology, neurochemistry and circuitry of the substantia gelatinosa Rolandi (lamina II) in mammalian spinal cord. Prog. Neurobiol. 169, 91\u2013134 (2018).","journal-title":"Prog. Neurobiol."},{"key":"25002_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1472-8206.2009.00767.x","volume":"24","author":"B Filipovi\u0107","year":"2010","unstructured":"Filipovi\u0107, B., Bach-Rojecky, L. & Lackovi\u0107, Z. Lasting reduction of postsurgical hyperalgesia after single injection of botulinum toxin type A in rat. Fundam. Clin. Pharmacol. 24, 43\u201345 (2010).","journal-title":"Fundam. Clin. Pharmacol."},{"key":"25002_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neuint.2018.03.010","volume":"116","author":"X Li","year":"2018","unstructured":"Li, X. et al. Botulinum toxin type A and gabapentin attenuate postoperative pain and NK1 receptor internalization in rats. Neurochem. Int. 116, 52\u201362 (2018).","journal-title":"Neurochem. Int."},{"key":"25002_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1136\/vr.102993","volume":"177","author":"S Vilhegas","year":"2015","unstructured":"Vilhegas, S. et al. Botulinum toxin type A as an adjunct in postoperative pain management in dogs undergoing radical mastectomy. Vet. Rec. 177, 391 (2015).","journal-title":"Vet. Rec."},{"key":"25002_CR24","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/01.sla.0000141156.56314.1f","volume":"240","author":"R Layeeque","year":"2004","unstructured":"Layeeque, R. et al. Botulinum toxin infiltration for pain control after mastectomy and expander reconstruction. Ann. Surg. 240, 608\u2013614 (2004).","journal-title":"Ann. Surg."},{"key":"25002_CR25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/BPO.0b013e3181aad628","volume":"29","author":"RC Hamdy","year":"2009","unstructured":"Hamdy, R. C. et al. Botulinum toxin type a injection in alleviating postoperative pain and improving quality of life in lower extremity limb lengthening and deformity correction: A pilot study. J. Pediatr. Orthop. 29, 427\u2013434 (2009).","journal-title":"J. Pediatr. Orthop."},{"key":"25002_CR26","doi-asserted-by":"publisher","first-page":"837","DOI":"10.4088\/JCP.13m08845","volume":"75","author":"M Magid","year":"2014","unstructured":"Magid, M. et al. Treatment of major depressive disorder using botulinum toxin a: A 24-week randomized, double-blind, placebo-controlled study. J. Clin. Psychiatry 75, 837\u2013844 (2014).","journal-title":"J. Clin. Psychiatry"},{"key":"25002_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1055\/s-0035-1559621","volume":"48","author":"M Magid","year":"2015","unstructured":"Magid, M. et al. Treating depression with botulinum toxin: A pooled analysis of randomized controlled trials. Pharmacopsychiatry 48, 205\u2013210 (2015).","journal-title":"Pharmacopsychiatry"},{"key":"25002_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-69773-7","volume":"10","author":"T Makunts","year":"2020","unstructured":"Makunts, T., Wollmer, M. A. & Abagyan, R. Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites. Sci. Rep. 10, 1\u20139 (2020).","journal-title":"Sci. Rep."},{"key":"25002_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jpsychires.2016.06.009","volume":"80","author":"E Finzi","year":"2016","unstructured":"Finzi, E. & Rosenthal, N. E. Emotional proprioception: Treatment of depression with afferent facial feedback. J. Psychiatr. Res. 80, 93\u201396 (2016).","journal-title":"J. Psychiatr. Res."},{"key":"25002_CR30","doi-asserted-by":"crossref","unstructured":"Jabbari, B. & Machado, D. Treatment of Refractory Pain with Botulinum Toxins-An Evidence-Based Reviewp me_1245 1594.1606. https:\/\/academic.oup.com\/painmedicine\/article\/12\/11\/1594\/1872311.","DOI":"10.1111\/j.1526-4637.2011.01245.x"},{"key":"25002_CR31","doi-asserted-by":"crossref","unstructured":"Blersch, W. et al. Botulinum toxin A and the cutaneous nociception in humans\u202f: A prospective, double-blind, placebo-controlled, randomized study. 205, 59\u201363 (2002).","DOI":"10.1016\/S0022-510X(02)00313-1"},{"key":"25002_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","volume":"107","author":"M Cui","year":"2004","unstructured":"Cui, M., Khanijou, S., Rubino, J. & Aoki, K. R. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 107, 125\u2013133 (2004).","journal-title":"Pain"},{"key":"25002_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00702-004-0265-1","volume":"112","author":"L Bach-Rojecky","year":"2005","unstructured":"Bach-Rojecky, L., Relja, M. & Lackovi\u0107, Z. Botulinum toxin type A in experimental neuropathic pain. J. Neural Transm. 112, 215\u2013219 (2005).","journal-title":"J. Neural Transm."},{"key":"25002_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2022.909835","volume":"15","author":"B Oehler","year":"2022","unstructured":"Oehler, B. et al. Evaluation of recombinant botulinum neurotoxin type A1 efficacy in peripheral inflammatory pain in Mice. Front. Mol. Neurosci. 15, 1\u201315 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"25002_CR35","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1523\/JNEUROSCI.0375-08.2008","volume":"28","author":"F Antonucci","year":"2008","unstructured":"Antonucci, F., Rossi, C., Gianfranceschi, L., Rossetto, O. & Caleo, M. Long-distance retrograde effects of botulinum neurotoxin A. J. Neurosci. 28, 3689\u20133696 (2008).","journal-title":"J. Neurosci."},{"key":"25002_CR36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.pbb.2009.08.012","volume":"94","author":"L Bach-Rojecky","year":"2009","unstructured":"Bach-Rojecky, L. & Lackovi\u0107, Z. Central origin of the antinociceptive action of botulinum toxin type A. Pharmacol. Biochem. Behav. 94, 234\u2013238 (2009).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"25002_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuroscience.2011.04.026","volume":"186","author":"I Matak","year":"2011","unstructured":"Matak, I., Bach-Rojecky, L., Filipovi\u0107, B. & Lackovi\u0107, Z. Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A. Neuroscience 186, 201\u2013207 (2011).","journal-title":"Neuroscience"},{"key":"25002_CR38","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.neuint.2012.05.001","volume":"61","author":"I Matak","year":"2012","unstructured":"Matak, I., Riederer, P. & Lackovi\u0107, Z. Botulinum toxin\u2019s axonal transport from periphery to the spinal cord. Neurochem. Int. 61, 236\u2013239 (2012).","journal-title":"Neurochem. Int."},{"key":"25002_CR39","doi-asserted-by":"publisher","first-page":"10329","DOI":"10.1523\/JNEUROSCI.0294-18.2018","volume":"38","author":"M Caleo","year":"2018","unstructured":"Caleo, M. et al. Transynaptic action of botulinum neurotoxin type a at central cholinergic boutons. J. Neurosci. 38, 10329\u201310337 (2018).","journal-title":"J. Neurosci."},{"key":"25002_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms19051392","volume":"19","author":"A Hawlitschka","year":"2018","unstructured":"Hawlitschka, A. & Wree, A. Experimental intrastriatal applications of botulinum neurotoxin-a: A review. Int. J. Mol. Sci. 19, 1\u201320 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"25002_CR41","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.celrep.2016.06.104","volume":"16","author":"E Bomba-Warczak","year":"2016","unstructured":"Bomba-Warczak, E. et al. Interneuronal transfer and distal action of tetanus toxin and botulinum neurotoxins A and D in central neurons. Cell Rep. 16, 1974\u20131987 (2016).","journal-title":"Cell Rep."},{"key":"25002_CR42","doi-asserted-by":"crossref","unstructured":"P\u00e9rier, C.  et al. Recombinant botulinum neurotoxin serotype A1 in vivo characterization. Pharmacol. Res. Perspect. (2021).","DOI":"10.1002\/prp2.857"},{"key":"25002_CR43","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jpain.2006.04.004","volume":"7","author":"H Obata","year":"2006","unstructured":"Obata, H., Eisenach, J. C., Hussain, H., Bynum, T. & Vincler, M. Spinal glial activation contributes to postoperative mechanical hypersensitivity in the rat. J. Pain 7, 816\u2013822 (2006).","journal-title":"J. Pain"},{"key":"25002_CR44","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/01.anes.0000264765.33673.6c","volume":"106","author":"A Romero-Sandoval","year":"2007","unstructured":"Romero-Sandoval, A. & Eisenach, J. C. Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision. Anesthesiology 106, 787\u2013794 (2007).","journal-title":"Anesthesiology"},{"key":"25002_CR45","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.brainres.2008.05.004","volume":"1219","author":"A Romero-Sandoval","year":"2008","unstructured":"Romero-Sandoval, A., Chai, N., Nutile-McMenemy, N. & DeLeo, J. A. A comparison of spinal Iba1 and GFAP expression in rodent models of acute and chronic pain. Brain Res. 1219, 116\u2013126 (2008).","journal-title":"Brain Res."},{"key":"25002_CR46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.pain.2009.06.037","volume":"145","author":"P Sahbaie","year":"2009","unstructured":"Sahbaie, P. et al. Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision. Pain 145, 341\u2013349 (2009).","journal-title":"Pain"},{"key":"25002_CR47","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00429-012-0500-8","volume":"219","author":"L Saur","year":"2014","unstructured":"Saur, L. et al. Physical exercise increases GFAP expression and induces morphological changes in hippocampal astrocytes. Brain Struct. Funct. 219, 293\u2013302 (2014).","journal-title":"Brain Struct. Funct."},{"key":"25002_CR48","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1006\/bbrc.1996.1112","volume":"224","author":"Y Imai","year":"1996","unstructured":"Imai, Y., Ibata, I., Ito, D., Ohsawa, K. & Kohsaka, S. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem. Biophys. Res. Commun. 224, 855\u2013862 (1996).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"25002_CR49","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4103\/2347-8659.139719","volume":"1","author":"I Hovens","year":"2014","unstructured":"Hovens, I., Nyakas, C. & Schoemaker, R. A novel method for evaluating microglial activation using ionized calcium-binding adaptor protein-1 staining: Cell body to cell size ratio. Neuroimmunol. Neuroinflammation 1, 82 (2014).","journal-title":"Neuroimmunol. Neuroinflammation"},{"key":"25002_CR50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejphar.2009.06.047","volume":"617","author":"C Favre-Guilmard","year":"2009","unstructured":"Favre-Guilmard, C., Auguet, M. & Chabrier, P. E. Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models. Eur. J. Pharmacol. 617, 48\u201353 (2009).","journal-title":"Eur. J. Pharmacol."},{"key":"25002_CR51","doi-asserted-by":"crossref","unstructured":"Favre-Guilmard, C., Chabrier, P.-E. & Kalinichev, M. Bilateral analgesic effects of abobotulinumtoxinA (Dysport\u00ae) following unilateral administration in the rat. Eur. J. Pain (United Kingdom) 21, (2017).","DOI":"10.1002\/ejp.995"},{"key":"25002_CR52","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejphar.2010.01.020","volume":"633","author":"L Bach-Rojecky","year":"2010","unstructured":"Bach-Rojecky, L., \u0160alkovi\u0107-Petri\u0161i\u0107, M. & Lackovi\u0107, Z. Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: Bilateral effect after unilateral injection. Eur. J. Pharmacol. 633, 10\u201314 (2010).","journal-title":"Eur. J. Pharmacol."},{"key":"25002_CR53","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0006-2952(00)00260-4","volume":"59","author":"J Purkiss","year":"2000","unstructured":"Purkiss, J., Welch, M., Doward, S. & Foster, K. Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: Involvement of two distinct mechanisms. Biochem. Pharmacol. 59, 1403\u20131406 (2000).","journal-title":"Biochem. Pharmacol."},{"key":"25002_CR54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1526-4610.2004.04007.x","volume":"44","author":"PL Durham","year":"2004","unstructured":"Durham, P. L., Cady, R., Cady, R. & Blumenfeld, A. J. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: Implications for migraine therapy. Headache 44, 35\u201343 (2004).","journal-title":"Headache"},{"key":"25002_CR55","doi-asserted-by":"crossref","unstructured":"Ishida, K., Kawamata, T., Tanaka, S., Shindo, T. & Kawamata, M. Calcitonin gene\u2013related peptide is involved in. 1068\u20131079 (2014).","DOI":"10.1097\/ALN.0000000000000364"},{"key":"25002_CR56","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/AAP.0000000000000091","volume":"39","author":"YW Chen","year":"2014","unstructured":"Chen, Y. W. et al. High-frequency transcutaneous electrical nerve stimulation attenuates postsurgical pain and inhibits excess substance P in rat dorsal root ganglion. Reg. Anesth. Pain Med. 39, 322\u2013328 (2014).","journal-title":"Reg. Anesth. Pain Med."},{"key":"25002_CR57","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","volume":"16","author":"M Zimmermann","year":"1983","unstructured":"Zimmermann, M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16, 109\u2013110 (1983).","journal-title":"Pain"},{"key":"25002_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-77643-5","volume":"10","author":"P P\u00e9rez Fraga","year":"2020","unstructured":"P\u00e9rez Fraga, P., Gerencs\u00e9r, L. & Andics, A. Human proximity seeking in family pigs and dogs. Sci. Rep. 10, 1\u201311 (2020).","journal-title":"Sci. Rep."},{"key":"25002_CR59","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2147\/JPR.S172300","volume":"11","author":"D Castel","year":"2018","unstructured":"Castel, D., Sabbag, I., Nasaev, E., Peng, S. & Meilin, S. Open field and a behavior score in PNT model for neuropathic pain in pigs. J. Pain Res. 11, 2279\u20132293 (2018).","journal-title":"J. Pain Res."},{"key":"25002_CR60","doi-asserted-by":"crossref","unstructured":"Retailleau, K., Martin, V., Lezmi, S., Nicoleau, C. & Maignel, J. The isolated mouse jejunal afferent nerve assay as a tool to assess the effect of botulinum neurotoxins in visceral nociception. Toxins (Basel). 14, (2022).","DOI":"10.3390\/toxins14030205"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25002-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25002-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25002-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T17:09:52Z","timestamp":1670951392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25002-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["25002"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-25002-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,13]]},"assertion":[{"value":"3 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Sylvie Cornet, Denis Carr\u00e9, Lorenzo Limana, Laurent Pons, Steven Evans, Stephane Lezmi and Mikhail Kalinichev were employees at Ipsen at the time the research was conducted David Castel, Sigal Meilin, and Ron Horne were employees of MD Bioscience at the time the research was conducted.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21555"}}